High-intensity interval training and moderate-intensity continuous training in adults with Crohn's disease: a pilot randomised controlled trial.
Adult
Anxiety
/ etiology
Cardiorespiratory Fitness
Crohn Disease
/ complications
Depression
/ etiology
Endurance Training
/ adverse effects
Fatigue
/ etiology
Feasibility Studies
Female
High-Intensity Interval Training
/ adverse effects
Humans
Male
Middle Aged
Patient Acceptance of Health Care
Patient Compliance
Pilot Projects
Quality of Life
Exercise therapy
Inflammatory bowel disease
Randomised controlled trial
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
29 Jan 2019
29 Jan 2019
Historique:
received:
27
09
2018
accepted:
21
01
2019
entrez:
31
1
2019
pubmed:
31
1
2019
medline:
9
2
2019
Statut:
epublish
Résumé
This study assessed the feasibility and acceptability of two common types of exercise training-high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT)-in adults with Crohn's disease (CD). In this mixed-methods pilot trial, participants with quiescent or mildly-active CD were randomly assigned 1:1:1 to HIIT, MICT or usual care control, and followed up for 6 months. The HIIT and MICT groups were offered three exercise sessions per week for the first 12 weeks. Feasibility outcomes included rates of recruitment, retention, outcome completion, and exercise attendance. Data were collected on cardiorespiratory fitness (e.g., peak oxygen uptake), disease activity, fatigue, quality of life, adverse events, and intervention acceptability (via interviews). Over 17 months, 53 patients were assessed for eligibility and 36 (68%) were randomised (47% male; mean age 36.9 [SD 11.2] years); 13 to HIIT, 12 to MICT, and 11 to control. The exercise session attendance rate was 62% for HIIT (288/465) and 75% for MICT (320/429), with 62% of HIIT participants (8/13) and 67% of MICT participants (8/12) completing at least 24 of 36 sessions. One participant was lost to follow-up. Outcome completion rates ranged from 89 to 97%. The mean increase in peak oxygen uptake, relative to control, was greater following HIIT than MICT (2.4 vs. 0.7 mL/kg/min). There were three non-serious exercise-related adverse events, and two exercise participants experienced disease relapse during follow-up. The findings support the feasibility and acceptability of the exercise programmes and trial procedures. A definitive trial is warranted. Physical exercise remains a potentially useful adjunct therapy in CD. [ID: ISRCTN13021107].
Sections du résumé
BACKGROUND
BACKGROUND
This study assessed the feasibility and acceptability of two common types of exercise training-high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT)-in adults with Crohn's disease (CD).
METHODS
METHODS
In this mixed-methods pilot trial, participants with quiescent or mildly-active CD were randomly assigned 1:1:1 to HIIT, MICT or usual care control, and followed up for 6 months. The HIIT and MICT groups were offered three exercise sessions per week for the first 12 weeks. Feasibility outcomes included rates of recruitment, retention, outcome completion, and exercise attendance. Data were collected on cardiorespiratory fitness (e.g., peak oxygen uptake), disease activity, fatigue, quality of life, adverse events, and intervention acceptability (via interviews).
RESULTS
RESULTS
Over 17 months, 53 patients were assessed for eligibility and 36 (68%) were randomised (47% male; mean age 36.9 [SD 11.2] years); 13 to HIIT, 12 to MICT, and 11 to control. The exercise session attendance rate was 62% for HIIT (288/465) and 75% for MICT (320/429), with 62% of HIIT participants (8/13) and 67% of MICT participants (8/12) completing at least 24 of 36 sessions. One participant was lost to follow-up. Outcome completion rates ranged from 89 to 97%. The mean increase in peak oxygen uptake, relative to control, was greater following HIIT than MICT (2.4 vs. 0.7 mL/kg/min). There were three non-serious exercise-related adverse events, and two exercise participants experienced disease relapse during follow-up.
CONCLUSIONS
CONCLUSIONS
The findings support the feasibility and acceptability of the exercise programmes and trial procedures. A definitive trial is warranted. Physical exercise remains a potentially useful adjunct therapy in CD. [ID: ISRCTN13021107].
Identifiants
pubmed: 30696423
doi: 10.1186/s12876-019-0936-x
pii: 10.1186/s12876-019-0936-x
pmc: PMC6352351
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
19Subventions
Organisme : Crohn's and Colitis UK
ID : SP2015/1
Références
J Crohns Colitis. 2008 Sep;2(3):202-7
pubmed: 21172211
Gastroenterology. 1998 Jul;115(1):36-41
pubmed: 9649456
Heart Lung Circ. 2015 Feb;24(2):149-57
pubmed: 25306500
Clin Exp Gastroenterol. 2017 Dec 22;11:1-11
pubmed: 29317842
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Crohns Colitis. 2014 Nov;8(11):1398-406
pubmed: 24856864
Am J Gastroenterol. 1999 Mar;94(3):697-703
pubmed: 10086654
J Crohns Colitis. 2017 Aug 1;11(8):1024
pubmed: 28186528
Br J Surg. 2017 Dec;104(13):1791-1801
pubmed: 28990651
J Physiol. 2012 Mar 1;590(5):1077-84
pubmed: 22289907
Trials. 2012 Nov 21;13:218
pubmed: 23171513
Ital J Gastroenterol Hepatol. 1999 Apr;31(3):205-10
pubmed: 10379481
Biomed Res Int. 2014;2014:429031
pubmed: 24877092
J Crohns Colitis. 2017 Oct 1;11(10):1286
pubmed: 28369347
Pilot Feasibility Stud. 2017 Apr 3;3:17
pubmed: 28373911
J Adv Nurs. 2008 Apr;62(1):107-15
pubmed: 18352969
Int J Sports Med. 2012 Aug;33(8):671-9
pubmed: 22562735
Int J Behav Nutr Phys Act. 2008 Nov 06;5:56
pubmed: 18990237
J Crohns Colitis. 2010 Feb;4(1):7-27
pubmed: 21122488
Digestion. 2015;91(3):239-47
pubmed: 25823689
Int J Sports Med. 2016 Jun;37(7):505-15
pubmed: 27116344
J Frailty Sarcopenia Falls. 2018 Jun 01;3(2):58-65
pubmed: 32300694
Inflamm Bowel Dis. 2016 Dec;22(12):2933-2942
pubmed: 27824653
BMC Public Health. 2016 Mar 05;16:227
pubmed: 26944952
Sports Med. 2015 Oct;45(10):1469-81
pubmed: 26243014
BMJ. 2016 Oct 24;355:i5239
pubmed: 27777223
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Int J Epidemiol. 2014 Aug;43(4):1272-83
pubmed: 24881045
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
PLoS One. 2016 Dec 9;11(12):e0167790
pubmed: 27936084
Oxid Med Cell Longev. 2017;2017:8148742
pubmed: 28656073
J Crohns Colitis. 2009 Dec;3(4):225-31
pubmed: 21172280
J Clin Epidemiol. 2000 Mar 1;53(3):297-306
pubmed: 10760641
Menopause. 2014 Oct;21(10):1099-105
pubmed: 24552980
Inflamm Bowel Dis. 2005 Mar;11(3):296-303
pubmed: 15735436
Clin J Sport Med. 2007 Sep;17(5):384-8
pubmed: 17873551